Drug maker agrees to $45M settlement with La
BATON ROUGE - GlaxoSmithKline has agreed to pay Louisiana $45 million to settle lawsuits accusing it of improperly marketing the diabetes drug Avandia and other drugs.
Attorneys for the state and company told a judge Friday that GSK also will pay an additional $7 million to the private lawyers who handled the state's lawsuits against the firm.
GSK further agreed to drop a lawsuit it filed last year against state Attorney General Buddy Caldwell. The suit claimed the private lawyers hired by Caldwell had a "personal financial interest" in the outcome of the litigation.
Attorney Wade Shows, one of the questioned lawyers, says the $45 million is part of a $229 million settlement with seven other states. He says the money will go directly to Louisiana's Medicaid program.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Sen. Troy Brown will spend the weekend in jail
Spanish Town Parade asks for usual irreverence but inclusion
Residents on edge as Comite River crests above flood stage
Baton Rouge residents gather to watch Trump's inauguration
Police believe illegal immigrant could be tied to other sex crimes